ADMA vs BLK · P/E 22, rev $426.5M vs P/E 27, rev $24.22B
ADMA Biologics Inc (ADMA) versus BlackRock Inc (BLK) — a side-by-side from cached financials, not a winner call.
ADMA Biologics Inc (ADMA) is a biotechnology company listed on US.
BlackRock Inc (BLK) is a asset management company listed on NYSE. It is led by Larry Fink.
Latest reported ADMA revenue for 2024-12-31 was $426.5M. Net income was $197.7M. Revenue was up 65.2% from 2023-12-31 to 2024-12-31. ADMA currently screens at market cap $4.39B and trailing P/E 21.9.
Latest reported BLK revenue for 2025-12-31 was $24.22B. Net income was $5.55B. Revenue was up 89.3% from 2024-12-31 to 2025-12-31. BLK currently screens at market cap $172.19B and trailing P/E 26.6.
ADMA currently screens at market cap $4.39B and trailing P/E 21.9. BLK currently screens at market cap $172.19B and trailing P/E 26.6.
Not investment advice. Open the ADMA and BLK stock pages for the full models.
Not investment advice.